Switching from Brand-Name to Generic Psychotropic Medications: A Literature Review

Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching

(2010) Howard C. Margolese et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Substitution of anticonvulsant drugs

(2010) Steinhoff   Therapeutics and Clinical Risk Management

Converting from brand-name to generic clozapine: A review of effectiveness and tolerability data

(2009) W. V. Bobo et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss

(2009) Maarten Treur et al.   BMC HEALTH SERVICES RESEARCH

Patientsʼ Attitudes towards Generic Substitution of Oral Atypical Antipsychotics

(2009) Beatriz Roman   CNS DRUGS

Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries

(2009) Pierre Emmanuel Paradis et al.   CURRENT MEDICAL RESEARCH AND OPINION

The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence

(2009) Mei Sheng Duh et al.   EXPERT OPINION ON PHARMACOTHERAPY

Comparison of Pharmacokinetic Profiles of Brand-Name and Generic Formulations of Citalopram and Venlafaxine

(2009) Franck Chenu et al.   JOURNAL OF CLINICAL PSYCHIATRY

The risks and costs of multiple-generic substitution of topiramate

(2009) M. S. Duh et al.   NEUROLOGY

Effects of Antiepileptic Drug Substitutions on Epileptic Events Requiring Acute Care

(2009) Karen L Rascati et al.   PHARMACOTHERAPY

Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product

(2008) T. P. Sabroe et al.   ACTA NEUROLOGICA SCANDINAVICA

Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting

(2008) Jacques LeLorier et al.   CURRENT MEDICAL RESEARCH AND OPINION

Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes

(2008) Woodie M. Zachry et al.   EPILEPSIA

Comparative daily profiles with different preparations of lamotrigine: A pilot investigation

(2008) Kirsten Annette Nielsen et al.   EPILEPSY & BEHAVIOR

Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease

(2008) Aaron S. Kesselheim   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical consequences of generic substitution of lamotrigine for patients with epilepsy

(2008) J. LeLorier et al.   NEUROLOGY

Generic substitution in the treatment of epilepsy: Case evidence of breakthrough seizures

(2008) M. J. Berg et al.   NEUROLOGY

Generic olanzapine: health authority opportunity or nightmare?

(2008) A Aleksander Araszkiewicz et al.   Expert Review of Pharmacoeconomics & Outcomes Research